Abstract:Immune-based therapeutic approaches for IBD, including anti-TNF therapy, have shown significant success during the last decade. Nevertheless, many patients are not responsive to these therapies and suffer from severe side effects. Therefore, an increased understanding of the fundamental immune mechanisms controlling gut inflammation is critical for the rational design and development of more effective therapies of IBD. Innate lymphoid cells (ILCs) have recently emerged as key players in regulating the balance between protective immunity and immunopathology at mucosal surfaces. However, the cellular and molecular pathways that control crosstalk between ILCs and intestinal epithelial cells during inflammation remain poorly understood. Our recent study revealed that Lymphotoxin (LT), a member of TNF superfamily of cytokines, produced by RORgt+ ILCs in the gut is critical for protection against the mucosal bacterial pathogen Citrobacter rodentium. In the present study, we aimed to determine how LT signaling controls ILCs to regulate the intestinal inflammation. An acute mouse model of IBD induced by dextran sodium sulfate (DSS) was used. WT and LT-beta receptor (LTbR)-deficient mice were treated with 3.5% DSS in drinking water for 5 days followed by normal water thereafter. Our data show that LTbR signaling is essential for protection and recovery from DSS-induced colitis. LTbR deficient mice failed to upregulate IL-22 in the colon and succumbed rapidly after DSS administration. By using RORgt-GFP reporter mice and cell sorting approach we found the impaired IL-22 production by distinct populations of ILCs in the colon after DSS-induced inflammation. Recent studies indicated a protective role of IL-22 in IBD by enhancing barrier integrity and epithelial innate immunity. We found that reduced IL-22 expression in LTbR-deficient mice was associated with defected mucin genes expression and impaired proliferation of intestinal epithelial cells after DSS-induced injury. Bone marrow transfer experiments revealed that LTbR expression on both bone marrow-derived and radioresistant stromal cells is required for the control of intestinal inflammation. To define which LTbR-expressing cells are essential for protection, we have generated mice with a specific inactivation of LTbR in intestinal epithelial cells, and bone marrow-derived cell populations. These mouse models will help us to further investigate the critical pathways to control intestinal inflammation. Our data indicate that LTbR signaling prevents intestinal inflammation by controlling the IL-22 protection pathway.

Lymphotoxin organizes contributions to host defense and metabolic illness from innate lymphoid cells.

LYMPHOTOXIN/LIGHT PATHWAY REGULATES ATHEROSCLEROSIS AND LIPID HOMEOSTASIS

Linking The Microbiota And Metabolic Disease With Lymphotoxin

Lymphotoxin in Physiology of Lymphoid Tissues – Implication for Antiviral Defense

Lymphotoxin Signalling in Immune Homeostasis and the Control of Microorganisms

The LTβR Signaling Pathway

Lymphotoxin-dependent Control of Innate Immune Responses in the Gut

Lymphotoxin-Dependent Control of Intestinal Inflammation

Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge

Lymphotoxins Serve as a Novel Orchestrator in T1D Pathogenesis

Lymphotoxin beta receptor-dependent control of lipid homeostasis

Lysosomal trafficking regulator Lyst links membrane trafficking to toll-like receptor–mediated inflammatory responses

Lymphotoxin Signalling in Tertiary Lymphoid Structures and Immunotherapy

A Role for Lymphotoxin in the Acquisition of Ly49 Receptors During NK Cell Development

The Interaction Between Lymphoid Tissue Inducer-Like Cells and T Cells in the Mesenteric Lymph Node Restrains Intestinal Humoral Immunity.

Transcriptional Regulation of Early T-Lymphocyte Development in Thymus

Contribution of the Lymphotoxin Beta Receptor to Liver Regeneration

Lymphotoxin αβ2 (Membrane Lymphotoxin) Is Critically Important for Resistance toLeishmania majorInfection in Mice

Contribution of the Lymphotoxin Receptor to Liver Regeneration1

The Complementation of Lymphotoxin Deficiency with LIGHT, a Newly Discovered TNF Family Member, for the Restoration of Secondary Lymphoid Structure and Function.

Lymphotoxin Αβ2 (membrane Lymphotoxin) is Critically Important for Resistance to Leishmania Major Infection in Mice